Old Web
English
Sign In
Acemap
>
authorDetail
>
Darlene Lu
Darlene Lu
Novartis
Cancer research
Medicine
Activator (genetics)
in patient
Tumor microenvironment
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase Ib study of the anti-TGF-β monoclonal antibody (mAb) NIS793 combined with spartalizumab (PDR001), a PD-1 inhibitor, in patients (pts) with advanced solid tumors.
2021
Journal of Clinical Oncology
Todd M. Bauer
Chia-Chi Lin
Richard Greil
Maria-Elisabeth Goebeler
Marie-Luise Huetter-Kroenke
Ignacio Garrido–Laguna
Armando Santoro
Antonella Perotti
Anna Spreafico
Thomas Yau
Markus Joerger
Viviana Cremasco
Mirek Dostalek
Marc Pelletier
Louise Barys
Darlene Lu
Vicky Katsanou
Claire Fabre
Toshihiko Doi
Show All
Source
Cite
Save
Citations (0)
A First-in-Human Study of YTB323, a Novel, Autologous CD19-Directed CAR-T Cell Therapy Manufactured Using the Novel T-Charge TM platform, for the Treatment of Patients (Pts) with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)
2021
Blood
Ian W. Flinn
Ulrich Jaeger
Nirav N. Shah
Didier Blaise
Javier Briones
Leyla Shune
Nicolas Boissel
Attilio Bondanza
Darlene Lu
Xu Zhu
Boris Engels
Jennifer Brogdon
Jennifer Marie Mataraza
Jaclyn Davis
Anne-Laure Marchal
Luisa Mariconti
Michele Moschetta
Laure Moutouh-de Parseval
Pere Barba
Michael Dickinson
Show All
Source
Cite
Save
Citations (0)
1